Mirago 25 Tablet ER

Product Introduction

Mirago 25 Tablet ER is an extended-release formulation of the medication Mirabegron, a selective beta-3 adrenergic agonist. Manufactured by [Pharmaceutical Company], it is primarily used for the management of overactive bladder (OAB) symptoms. The “ER” in its name signifies “Extended Release,” which means the tablet is designed to release the active ingredient gradually over time, providing sustained relief and minimizing the need for frequent dosing.

Mirabegron, the active component, acts on the beta-3 adrenergic receptors in the bladder, leading to relaxation of the detrusor muscle. This helps increase the bladder’s capacity and reduces symptoms associated with an overactive bladder, such as frequent or urgent urination and urinary incontinence.

Uses of Mirago 25 Tablet ER

Mirago 25 Tablet ER is prescribed for the treatment of overactive bladder (OAB) symptoms in adults. These symptoms include:

• Urinary Urgency: A sudden and compelling need to urinate that is difficult to defer.
• Urinary Frequency: The need to urinate more often than usual.
• Urinary Incontinence: Involuntary leakage of urine, often occurring with urgency.

The medication is particularly useful for individuals who experience these symptoms due to a condition known as overactive bladder, which can significantly impact quality of life. Mirago 25 Tablet ER helps manage these symptoms by improving bladder control and increasing bladder capacity.

Benefits of Mirago 25 Tablet ER

Mirago 25 Tablet ER offers several benefits for managing OAB symptoms:

• Extended Relief: The extended-release formulation allows for sustained action throughout the day, reducing the need for multiple doses and improving adherence to the treatment regimen.
• Improved Bladder Control: By stimulating beta-3 adrenergic receptors, Mirago 25 Tablet ER helps relax the bladder muscle, leading to increased bladder capacity and reduced urgency and frequency of urination.
• Non-Anticholinergic: Unlike some other OAB treatments, Mirago 25 Tablet ER does not work as an anticholinergic. This can be advantageous for patients who may have contraindications or intolerances to anticholinergic medications.
• Quality of Life: Effective management of OAB symptoms can lead to a significant improvement in overall quality of life, including better sleep, increased comfort, and reduced anxiety related to urinary issues.

Side Effects of Mirago 25 Tablet ER

While Mirago 25 Tablet ER is generally well-tolerated, it may cause some side effects. Common side effects include:

• Increased Blood Pressure: Mirabegron can cause a modest increase in blood pressure, so patients with hypertension or cardiovascular conditions should be monitored regularly.
• Headache: Some individuals may experience headaches as a side effect of the medication.
• Nasopharyngitis: Symptoms like a sore throat, nasal congestion, or other upper respiratory tract infections may occur.
• Dry Mouth: This is a relatively common side effect and can be managed with increased fluid intake or use of saliva substitutes.
• Constipation: Some users may experience constipation, which can often be alleviated with dietary adjustments and increased fiber intake.